Worth Venture Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,352
Closed -$150K 130
2020
Q1
$150K Buy
+10,352
New +$150K 0.09% 74